MaxCyte Investor Presentation Deck
August 2023, 22 slides
  1. MaxCyte
  2. Related Decks
  3. Investor Presentation Decks
driving the next generation of cell based therapies ante | MaxCyte
disclaimer | MaxCyte
a leading provider of cell engineering platform technologies | MaxCyte
who we are collaborative innovative and experienced partner | MaxCyte
leading partner for complex cellular engineering case ditas | MaxCyte
value creation from | MaxCyte
continued investment in cell and gene therapy i total amount of global financings | MaxCyte
expert platform addresses industry challenges challenges solutions | MaxCyte
the expert platform enabling non viral cell engineering ats a | MaxCyte
business model drug discovery market | MaxCyte
business model cell therapy market | MaxCyte
example typical single product revenues from a representative license deal | MaxCyte
partnerships offer significant revenue upside particularly in commercial a | MaxCyte
partnership commercial milestone events | MaxCyte
partnerships near and long term revenue potential with strong upside in commercial opportunity | MaxCyte
enabled active clinical trials | MaxCyte
enables next generation cell therapies across a variety of diseases | MaxCyte
update | MaxCyte
key financial highlights | MaxCyte
continued growth over the last years | MaxCyte
summary and outlook for | MaxCyte
thank you any questions | MaxCyte
See More
MaxCyte
Investor Presentation Decks
Medical Devices Decks
Healthcare Decks
Explore Topics
Cell therapy
Clinical trial
Recent decks by MaxCyte
Investor Presentation
January 2024
Results
November 2023
Investor Presentation
October 2023
Investor Presentation
May 2023
See all presentations by MaxCyte (8 decks)
Related decks
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
October 2023
BioNTech
Results
August 2021
Genelux
Investor Presentation
February 2024
Immix Biopharma
Investor Presentation
September 2023
Immix Biopharma
Investor Presentation
March 2024
Recent decks by MaxCyte
See all presentations (8 decks)
Investor Presentation
January 2024
Results
November 2023
Investor Presentation
October 2023
Investor Presentation
May 2023
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
October 2023
BioNTech
Results
August 2021
Genelux
Investor Presentation
February 2024
Immix Biopharma
Investor Presentation
September 2023
Immix Biopharma
Investor Presentation
March 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights